Saturday, September 28, 2019 6:19:11 AM
After receiving a bachelor's degree in economics as well as a bachelor's in political science from the Wharton School of the University of Pennsylvania, Steven Boyd joined McKinsey & Co. as an analyst.
Two years later he launched his hedge fund career when he worked as an analyst at SAB Capital Management, a value-oriented long-short equity hedge fund. He then had a one-year pit stop as an associate at York Capital Management, focusing primarily on investments in consumer and health care equities before joining Senator Investment Group in February 2008 as its first analyst — before it actually launched.
Boyd founded Armistice Capital in 2012. The firm is a global, long-short, value-oriented, event-driven hedge fund focused primarily on the health care and consumer sectors. At the end of 2017, the firm had $1.25 billion of regulatory assets, according to an SEC filing. In 2017, Boyd was named to the board of directors of Cerecor, a clinical-stage biopharmaceutical company and the hedge fund’s largest individual U.S. long position.
https://www.institutionalinvestor.com/article/b18v4cgb6hkmqp/Steven-Boyd
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM